Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Lynn A. Paxton"'
Autor:
Abdullah S. Ali, Narjis G. Thawer, Bakar Khatib, Haji H. Amier, Joseph Shija, Mwinyi Msellem, Abdul-wahid Al-mafazy, Issa A. Garimo, Humphrey Mkali, Mahdi M. Ramsan, Jessica M. Kafuko, Lynn A. Paxton, Richard Reithinger, Jeremiah M. Ngondi
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-8 (2017)
Abstract Background Mass drug administration (MDA) appears to be effective in reducing the risk of malaria parasitaemia. This study reports on programmatic coverage and compliance of MDA using artemisinin-based combination therapy (ACT) in four shehi
Externí odkaz:
https://doaj.org/article/87a3ebf9bf0f4541807eec8bfc54d5b2
Autor:
Jeremiah M. Ngondi, Deus S. Ishengoma, Stephanie M. Doctor, Kyaw L. Thwai, Corinna Keeler, Sigsbert Mkude, Oresto M. Munishi, Ritha A. Willilo, Shabbir Lalji, Naomi Kaspar, Chonge Kitojo, Lynn A. Paxton, Nicholas J. Hathaway, Jeffrey A. Bailey, Jonathan J. Juliano, Steven R. Meshnick, Julie Gutman
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-7 (2017)
Abstract Background Malaria in pregnancy (MiP) remains a major public health challenge in areas of high malaria transmission. Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended to prevent the adve
Externí odkaz:
https://doaj.org/article/eec9173b199344ec864423eabcdc87ad
Autor:
Felicia P. Hardnett, Peter H. Kilmarx, Lebogang Makgekgenene, Tebogo M. Segolodi, Deborah A. Gust, Charles K. Malotte, Lynn A. Paxton, Charles E. Rose, Faith L. Henderson, Fatma A. Soud, Poloko Kebaabetswe
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 73:556-563
OBJECTIVE Among participants of a clinical trial to test the efficacy of tenofovir/emtricitabine in protecting heterosexual men and women living in Botswana from HIV infection, the aim was to determine (1) if sexual risk behavior, specifically condom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36674f3b9622591cf35ca0d13e612915
https://doi.org/10.1097/qai.0000000000001143
https://doi.org/10.1097/qai.0000000000001143
Autor:
Abdunoor M. Kabanywanyi, Billy Ngasala, Troy Martin, Deus S. Ishengoma, Erasmus Kamugisha, George Greer, Ally Mohamed, Celine I. Mandara, Eldin Talundzic, Naomi W. Lucchi, Ritha Njau, Muhidin K. Mahende, Venkatachalam Udhayakumar, Chonge Kitojo, Marian Warsame, Florida Muro, Sigsbert Mkude, Filbert Francis, Renata Mandike, Lynn A. Paxton, Frank Chacky, Meera Venkatesan, Reginald A. Kavishe, Eric S. Halsey
Publikováno v:
Malaria Journal
Malaria Journal, Vol 18, Iss 1, Pp 1-13 (2019)
Malaria Journal, Vol 18, Iss 1, Pp 1-13 (2019)
Background The World Health Organization recommends regular therapeutic efficacy studies (TES) to monitor the performance of first and second-line anti-malarials. In 2016, efficacy and safety of artemether-lumefantrine (AL) for the treatment of uncom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a7ad948a5a22a6b211af1e2c262e71
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-381123
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-381123
Autor:
Jose Gerardo Garcia-Lerma, Susan Ruone, Walid Heneine, Debra L. Hanson, Allan W. Taylor, Lynn A. Paxton, Tony McLaurin, John T. Brooks
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
We describe HIV-1 evolutionary dynamics in the 4 participants from the TDF2-PrEP trial who became HIV-1 infected while prescribed emtricitabine and tenofovir disoproxil fumarate (FTC/TDF). A
We describe HIV-1 evolutionary dynamics in the 4 participants from the TDF2-PrEP trial who became HIV-1 infected while prescribed emtricitabine and tenofovir disoproxil fumarate (FTC/TDF). A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4001b2a0bdea5c5e280ba6f687585611
https://doi.org/10.1097/qai.0000000000000921
https://doi.org/10.1097/qai.0000000000000921
Autor:
Michael C. Thigpen, Tebogo M. Segolodi, Clyde E. Hart, Craig W. Hendrix, Alison Swaims-Kohlmeier, Teresa L. Parsons, Carolyn Dawson, Chou Pong Pau, Dawn K. Smith, Richard E. Haaland, Angela Holder, Lynn A. Paxton
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 75:e86-e88
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029a877a98e7858c9bb6c141e0abe968
https://doi.org/10.1097/qai.0000000000001324
https://doi.org/10.1097/qai.0000000000001324
Autor:
Manoj Leethochawalit, Kachit Choopanya, Pravan Suntharasamai, Somyot Kittimunkong, Marcel E. Curlin, Philip A. Mock, Suphak Vanichseni, Lynn A. Paxton, Janet M. McNicholl, Anchalee Warapronmongkholkul, Udomsak Sangkum, Roman Gvetadze, Michael Martin, Sithisat Chiamwongpaet, Supawadee Na-pompet
Publikováno v:
AIDS. 29:819-824
OBJECTIVE To describe participant adherence to daily oral tenofovir in an HIV preexposure prophylaxis (PrEP) trial, examine factors associated with adherence, and assess the impact of adherence on the risk of HIV infection. DESIGN The Bangkok Tenofov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932cbbf5da02ef99b79794aa367aea3c
https://doi.org/10.1097/qad.0000000000000613
https://doi.org/10.1097/qad.0000000000000613
Autor:
Joseph Shija, Richard Reithinger, Lynn A. Paxton, Haji H. Amier, Abdul Wahid Al-Mafazy, Mwinyi I. Msellem, Bakar Khatib, Jeremiah Ngondi, Narjis G. Thawer, Mahdi Ramsan, Abdullah S. Ali, Jessica M. Kafuko, Issa Garimo, Humphrey R. Mkali
Publikováno v:
Malaria Journal
Malaria Journal, Vol 16, Iss 1, Pp 1-8 (2017)
Malaria Journal, Vol 16, Iss 1, Pp 1-8 (2017)
Background Mass drug administration (MDA) appears to be effective in reducing the risk of malaria parasitaemia. This study reports on programmatic coverage and compliance of MDA using artemisinin-based combination therapy (ACT) in four shehias (small
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b370a77504da4093b1489355f5f84ec2
http://europepmc.org/articles/PMC5557321
http://europepmc.org/articles/PMC5557321
Autor:
John T. Brooks, Onkabetse Matlhaba, Tebogo M. Segolodi, Lovemore Ian Chirwa, Jin-Fen Li, Faith L. Henderson, Charles E. Rose, Richard W. Niska, Jeffrey A. Johnson, Michael C. Thigpen, Lynn A. Paxton
Publikováno v:
AIDS. 28:223-226
We examined CD4 cell count and plasma viral load patterns among Botswana TDF/FTC Oral HIV Prophylaxis Trial (TDF2 study) participants who seroconverted, comparing participants assigned to receive tenofovir/emtricitabine with participants assigned to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f622a5c60c17bb74b3081261d9bc901
https://doi.org/10.1097/qad.0000000000000102
https://doi.org/10.1097/qad.0000000000000102
Autor:
Lynn A. Paxton
Publikováno v:
Future Virology. 8:1207-1218
HIV pre-exposure prophylaxis (PrEP) with daily oral tenofovir disoproxil fumarate (TDF) or TDF–emtricitabine (FTC) has been shown to be effective against sexual and injection-drug related HIV acquisition in four out of six large clinical trials. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba1c9dc38900cf0606366a1e16951e77
https://doi.org/10.2217/fvl.13.111
https://doi.org/10.2217/fvl.13.111